Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA Conference Proceedings uri icon

Overview

Authors

  • Authorship

    • PROF Michael Hofman
    • THANG S-P
    • MURPHY D
    • SCALZO M
    • HICKS RJ
    • VIOLET J
    • SANDHU S
    • EU P
    • PRICE J
    • AKHURST T
    • IRAVANI A
    • KONG G
    • RAVI-KUMAR A
    • WILLIAMS S

Published in

  • Annals of Oncology

Time

Date/time value

  • 2017

Additional Document Info

Parent Title

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)
  • ANNALS OF ONCOLOGY

Volume

  • 28

Publisher

  • Oxford University Press